317 related articles for article (PubMed ID: 22556403)
41. Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer.
Pauloski BR; Rademaker AW; Logemann JA; Discekici-Harris M; Mittal BB
Head Neck; 2015 Nov; 37(11):1575-82. PubMed ID: 24909649
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
43. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
44. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
45. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.
Claus F; Duthoy W; Boterberg T; De Gersem W; Huys J; Vermeersch H; De Neve W
Oral Oncol; 2002 Sep; 38(6):597-604. PubMed ID: 12167438
[TBL] [Abstract][Full Text] [Related]
46. Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: a planning comparison.
Broggi S; Perna L; Bonsignore F; Rinaldin G; Fiorino C; Chiara A; Frigerio C; Butti I; Sangalli G; Dell'Oca I; Di Muzio N; Cattaneo GM; Declich F
Phys Med; 2014 Dec; 30(8):973-9. PubMed ID: 25113943
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
[TBL] [Abstract][Full Text] [Related]
48. Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?
Samuels MA; Freedman LM; Elsayyad N
Future Oncol; 2016 Nov; 12(22):2615-2630. PubMed ID: 27502431
[TBL] [Abstract][Full Text] [Related]
49. Obtaining normal tissue constraints using intensity modulated radiotherapy (IMRT) in patients with oral cavity, oropharyngeal, and laryngeal carcinoma.
Skinner WK; Muse ED; Yaparpalvi R; Guha C; Garg MK; Kalnicki S
Med Dosim; 2009; 34(4):279-84. PubMed ID: 19854386
[TBL] [Abstract][Full Text] [Related]
50. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
[TBL] [Abstract][Full Text] [Related]
51. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
52. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
53. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
54. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
[TBL] [Abstract][Full Text] [Related]
55. Erratum to "Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275].
Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
Radiother Oncol; 2006 Jul; 80(1):107-8. PubMed ID: 16972340
[No Abstract] [Full Text] [Related]
56. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
57. Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy.
Gensheimer MF; Hummel-Kramer SM; Cain D; Quang TS
Med Dosim; 2015; 40(3):232-4. PubMed ID: 25704638
[TBL] [Abstract][Full Text] [Related]
58. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
59. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
[TBL] [Abstract][Full Text] [Related]
60. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
Kil WJ; Camphausen K
Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
